Supervsion of Ph.D. Camilla Frimor

Mark Andrew Ainsworth

Klinisk Institut
KI, OUH, Forskningsenhed for Medicinsk gastroenterologi (Odense)

Vejledning

Beskrivelse

Titel of Ph.D. project: Guidance of Vedolizumab and Ustekinumab dosage by therapeutic drug monitoring, superior to dosage assessment by clinical evaluation?

Periode	01/09/2024 → 31/08/2027
Målgruppe	Ph.d